Related references
Note: Only part of the references are listed.Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis
Otavio Cabral-Marques et al.
AUTOIMMUNITY REVIEWS (2016)
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies
Michele M. Luchetti et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor Autoantibodies in Systemic Sclerosis
Gianluca Moroncini et al.
ARTHRITIS & RHEUMATOLOGY (2015)
A Reactive Oxygen Species-Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis
Tatiana Spadoni et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series)
Joshua P. Fessel et al.
PULMONARY CIRCULATION (2015)
Failed Degradation of JunB Contributes to Overproduction of Type I Collagen and Development of Dermal Fibrosis in Patients With Systemic Sclerosis
Markella Ponticos et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Mammalian Target of Rapamycin: A Novel Pathway in Vascular Calcification
Augusto C. Montezano et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts
Zenshiro Tamaki et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor
Monique R. Arts et al.
PLOS ONE (2014)
Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis
Silvia Svegliati et al.
SCIENCE SIGNALING (2014)
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
Paolo Fraticelli et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
David Launay et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Review: Evidence That Systemic Sclerosis Is a Vascular Disease
Marco Matucci-Cerinic et al.
ARTHRITIS AND RHEUMATISM (2013)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Smooth Muscle Cell Plasticity Fact or Fiction?
Anh T. Nguyen et al.
CIRCULATION RESEARCH (2013)
Mammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury
Assaad A. Eid et al.
DIABETES (2013)
mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects
Elena A. Goncharova
FASEB JOURNAL (2013)
Race and Association With Disease Manifestations and Mortality in Scleroderma A 20-Year Experience at the Johns Hopkins Scleroderma Center and Review of the Literature
Allan C. Gelber et al.
MEDICINE (2013)
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
Gabriela Riemekasten et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Treatment With Rapamycin Prevents Fibrosis in Tight-Skin and Bleomycin-Induced Mouse Models of Systemic Sclerosis
Ayumi Yoshizaki et al.
ARTHRITIS AND RHEUMATISM (2010)
Cellular and molecular aspects of vascular dysfunction in systemic sclerosis
Maria Trojanowska
NATURE REVIEWS RHEUMATOLOGY (2010)
Rapamycin Versus Methotrexate in Early Diffuse Systemic Sclerosis Results From a Randomized, Single-Blind Pilot Study
Tien-I Karleen Su et al.
ARTHRITIS AND RHEUMATISM (2009)
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
Attilio Olivieri et al.
BLOOD (2009)
Vascular Disease in Scleroderma
Fredrick M. Wigley
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
Alfiya Akhmetshina et al.
FASEB JOURNAL (2008)
Vascular disease in scleroderma: Mechanisms of vascular injury
Bashar Kahaleh
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Developmental basis of vascular smooth muscle diversity
Mark W. Majesky
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Chun-Chi Liang et al.
NATURE PROTOCOLS (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity
S. S. M. Rensen et al.
NETHERLANDS HEART JOURNAL (2007)
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis
CA Davies et al.
HUMAN PATHOLOGY (2006)
Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex
DD Sarbassov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2 - Amplification of ROS and Ras in systemic sclerosis fibroblasts
S Svegliati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis
VS Rajkumar et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis
O Distler et al.
CIRCULATION RESEARCH (2004)
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
GK Owens et al.
PHYSIOLOGICAL REVIEWS (2004)
Novel gp91phox homologues in vascular smooth muscle cells -: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways
B Lassègue et al.
CIRCULATION RESEARCH (2001)
Mechanisms of neointima formation and remodeling in the porcine coronary artery
T Christen et al.
CIRCULATION (2001)
Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury
CP Regan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
